Skip to main content
Erschienen in: Current Gastroenterology Reports 4/2016

01.04.2016 | Small Intestine (D Sachar, Section Editor)

Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)

verfasst von: Mathieu Uzzan, Huaibin M. Ko, Saurabh Mehandru, Charlotte Cunningham-Rundles

Erschienen in: Current Gastroenterology Reports | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Common variable immune deficiency (CVID) and chronic granulomatous disease (CGD) are two of the well-characterized primary immune deficiencies with distinct pathologic defects. While CVID is predominantly a disorder of the adaptive immune system, in CGD, innate immunity is impaired. In both syndromes, the clinical manifestations include an increased susceptibility to infections and a number of non-infectious, inflammatory conditions including systemic autoimmunity, as well as organ-specific pathology. Among the organ-associated disorders, gastrointestinal (GI) manifestations are one of the most intractable. As such, non-infectious inflammatory disorders of the GI tract are clinically challenging as they have protean manifestations, often resembling inflammatory bowel disease (IBD) or celiac disease, are notoriously difficult to treat, and hence are associated with significant morbidity and mortality. Therefore, assessing the pathogenesis and defining appropriate therapeutic approaches for GI disease in patients with CVID and CGD is imperative.
Literatur
1.
Zurück zum Zitat Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. ICON: common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.CrossRefPubMed Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. ICON: common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.CrossRefPubMed
2.
Zurück zum Zitat Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015. Epub ahead of print. Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015. Epub ahead of print.
3.
Zurück zum Zitat Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.CrossRefPubMedPubMedCentral Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–54.CrossRefPubMed Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–54.CrossRefPubMed
6.••
Zurück zum Zitat Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105:2262–75. ••50 patients with CVID-associated GI symptoms were assessed with chronic diarrhea as the most frequent clinical feature (92%). Pathological small bowel assessment was remarkable for the high frequency of increased IEL (75%) and villous atrophy (50%) whereas plasma cells were almost always absent. IVIg desmonstrated no effect on GI symptoms.CrossRefPubMed Malamut G, Verkarre V, Suarez F, Viallard J-F, Lascaux A-S, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105:2262–75. ••50 patients with CVID-associated GI symptoms were assessed with chronic diarrhea as the most frequent clinical feature (92%). Pathological small bowel assessment was remarkable for the high frequency of increased IEL (75%) and villous atrophy (50%) whereas plasma cells were almost always absent. IVIg desmonstrated no effect on GI symptoms.CrossRefPubMed
7.
Zurück zum Zitat Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800–12.CrossRefPubMed Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31:1800–12.CrossRefPubMed
8.
Zurück zum Zitat Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163:69–74.CrossRefPubMed Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163:69–74.CrossRefPubMed
9.
Zurück zum Zitat Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41:366–70.CrossRefPubMedPubMedCentral Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut. 1997;41:366–70.CrossRefPubMedPubMedCentral
10.••
Zurück zum Zitat Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol Nature Publishing Group. 2015;110:320–7. ••Stools and small bowel biopsies from 8 CVID patients with CE were analysed by PCR for the presence of Norovirus RNA and compared to 10 CVID patients without GI disorder. All 8 patients with CVID-associated CE showed evidence of chronic Norovirus carriage (none in the control group). Remarkably, 3 patients with Norovirus clearance (one spontaneously, 2 with Ribavirin therapy) exhibited complete symptomatic and histological recovery.CrossRef Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol Nature Publishing Group. 2015;110:320–7. ••Stools and small bowel biopsies from 8 CVID patients with CE were analysed by PCR for the presence of Norovirus RNA and compared to 10 CVID patients without GI disorder. All 8 patients with CVID-associated CE showed evidence of chronic Norovirus carriage (none in the control group). Remarkably, 3 patients with Norovirus clearance (one spontaneously, 2 with Ribavirin therapy) exhibited complete symptomatic and histological recovery.CrossRef
11.
Zurück zum Zitat van de Ven AAJM, Janssen WJM, Schulz LS, van Loon AM, Voorkamp K, Sanders EAM, et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. J Clin Immunol. 2014;34:962–70.CrossRefPubMed van de Ven AAJM, Janssen WJM, Schulz LS, van Loon AM, Voorkamp K, Sanders EAM, et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. J Clin Immunol. 2014;34:962–70.CrossRefPubMed
12.
Zurück zum Zitat Maarschalk-Ellerbroek L, Oldenburg B, Mombers I, Hoepelman A, Brosens L, Offerhaus G, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45:320–3.CrossRefPubMed Maarschalk-Ellerbroek L, Oldenburg B, Mombers I, Hoepelman A, Brosens L, Offerhaus G, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45:320–3.CrossRefPubMed
13.
Zurück zum Zitat Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther. 2016;43(3):334–45.CrossRefPubMed Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther. 2016;43(3):334–45.CrossRefPubMed
14.
Zurück zum Zitat Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.CrossRefPubMed Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–63.CrossRefPubMed
15.
Zurück zum Zitat Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45:77–81.CrossRefPubMedPubMedCentral Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45:77–81.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Desar IME, van Deuren M, Sprong T, Jansen JBMJ, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156:434–9.CrossRefPubMedPubMedCentral Desar IME, van Deuren M, Sprong T, Jansen JBMJ, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156:434–9.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20:1240–52.CrossRefPubMed Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20:1240–52.CrossRefPubMed
18.
Zurück zum Zitat Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17:251–9.CrossRefPubMedPubMedCentral Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17:251–9.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.CrossRefPubMed Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.CrossRefPubMed
20.
Zurück zum Zitat Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.e11. Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116–26.e11.
21.
Zurück zum Zitat Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.CrossRefPubMed Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.CrossRefPubMed
22.
Zurück zum Zitat Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131:748–56.CrossRefPubMed Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131:748–56.CrossRefPubMed
23.
Zurück zum Zitat Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet Elsevier Ltd. 2012;380:1590–605.CrossRef Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet Elsevier Ltd. 2012;380:1590–605.CrossRef
24.
Zurück zum Zitat Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, et al. Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med. 2004;351:2069–79.CrossRefPubMed Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, et al. Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med. 2004;351:2069–79.CrossRefPubMed
25.
Zurück zum Zitat Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, et al. Ustekinumab induction and maintenance therapy in refractory Crohn’s disease. N Engl J Med. 2012;367:1519–28.CrossRefPubMed Sandborn WJ, Gasink C, Gao L-L, Blank MA, Johanns J, Guzzo C, et al. Ustekinumab induction and maintenance therapy in refractory Crohn’s disease. N Engl J Med. 2012;367:1519–28.CrossRefPubMed
27.••
Zurück zum Zitat Cols M, Rahman A, Maglione PJ, Garcia-Carmona Y, Simchoni N, Ko H-BM, et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol. 2015; ••Lymphoid cells were identified and analyzed from peripheral blood and GI tissue of CVID patients (31 with and 24 without inflammatory/autoimmune complications). In the blood of CVID patients with inflammatory associated disorders, type 3 ILC and -associated cytokines were expanded. Moreover, numerous IFNγ + RORγt + CD3 - were found in GI biopsies of patients with IBD-like suggesting a role in this mucosal inflammation. Cols M, Rahman A, Maglione PJ, Garcia-Carmona Y, Simchoni N, Ko H-BM, et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol. 2015; ••Lymphoid cells were identified and analyzed from peripheral blood and GI tissue of CVID patients (31 with and 24 without inflammatory/autoimmune complications). In the blood of CVID patients with inflammatory associated disorders, type 3 ILC and -associated cytokines were expanded. Moreover, numerous IFNγ + RORγt + CD3 - were found in GI biopsies of patients with IBD-like suggesting a role in this mucosal inflammation.
28.
Zurück zum Zitat Sanges M, Spadaro G, Miniero M, Mattera D, Sollazzo R, D’Armiento FP, et al. Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn’s-like phenotype: report of a case. Eur Rev Med Pharmacol Sci. 2015;19:2641–5.PubMed Sanges M, Spadaro G, Miniero M, Mattera D, Sollazzo R, D’Armiento FP, et al. Efficacy of subcutaneous immunoglobulins in primary immunodeficiency with Crohn’s-like phenotype: report of a case. Eur Rev Med Pharmacol Sci. 2015;19:2641–5.PubMed
29.
Zurück zum Zitat Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31:879–82.CrossRefPubMedPubMedCentral Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31:879–82.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012;138:185–9.CrossRefPubMed Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012;138:185–9.CrossRefPubMed
31.
Zurück zum Zitat Boursiquot J-N, Gérard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33:84–95.CrossRefPubMed Boursiquot J-N, Gérard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33:84–95.CrossRefPubMed
33.
Zurück zum Zitat Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2012;33:30–9.CrossRefPubMedPubMedCentral Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2012;33:30–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012:301–5. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012:301–5.
35.
Zurück zum Zitat Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170–82.CrossRefPubMed Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol. 1992;16:1170–82.CrossRefPubMed
36.
Zurück zum Zitat Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1–7.CrossRefPubMedPubMedCentral Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1–7.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431–8.CrossRefPubMed Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431–8.CrossRefPubMed
38.
Zurück zum Zitat De Petris G, Dhungel BM, Chen L, Chang Y-HH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22:600–6.CrossRefPubMed De Petris G, Dhungel BM, Chen L, Chang Y-HH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22:600–6.CrossRefPubMed
39.
Zurück zum Zitat Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150:306–11.CrossRefPubMedPubMedCentral Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150:306–11.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, Benítez-Rodríguez B, Ramos-Lora M. Crohn’s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab. Rev Esp Enferm Dig. 2013;105:299–302.CrossRefPubMed Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, Benítez-Rodríguez B, Ramos-Lora M. Crohn’s-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab. Rev Esp Enferm Dig. 2013;105:299–302.CrossRefPubMed
42.
Zurück zum Zitat Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.CrossRef Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.CrossRef
43.
Zurück zum Zitat van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.CrossRefPubMedPubMedCentral van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Jones LBKR, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.CrossRefPubMedPubMedCentral Jones LBKR, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152:211–8.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64.CrossRefPubMed Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64.CrossRefPubMed
46.
Zurück zum Zitat Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, et al. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2013;33:1302–9.CrossRefPubMed Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, et al. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. J Clin Immunol. 2013;33:1302–9.CrossRefPubMed
47.••
Zurück zum Zitat Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655–62.e8. ••68 on 98 analyzed CGD patients experienced inflammatory episodes. GI tract was the most commonly affected organ (88% of episodes) and patients with X-linked CGD were at higher risk of inflammatory episodes compared to patients with autosomal-recessive CGD (RR 2.2, 95% CI = 1.5-3.5). Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134:655–62.e8. ••68 on 98 analyzed CGD patients experienced inflammatory episodes. GI tract was the most commonly affected organ (88% of episodes) and patients with X-linked CGD were at higher risk of inflammatory episodes compared to patients with autosomal-recessive CGD (RR 2.2, 95% CI = 1.5-3.5).
48.
Zurück zum Zitat Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis. 2006;8:637–44.CrossRefPubMed Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis. 2006;8:637–44.CrossRefPubMed
49.
Zurück zum Zitat Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8.CrossRefPubMed Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462–8.CrossRefPubMed
50.
Zurück zum Zitat Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, et al. High levels of Crohn’s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. Elsevier Inc.; 2011;138:14–22. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, et al. High levels of Crohn’s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. Elsevier Inc.; 2011;138:14–22.
51.
Zurück zum Zitat Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006;2:e28.CrossRefPubMedPubMedCentral Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006;2:e28.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Marks DJB, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–24.CrossRefPubMed Marks DJB, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn’s disease. Am J Gastroenterol. 2009;104:117–24.CrossRefPubMed
53.
Zurück zum Zitat Alimchandani M, Lai J-P, Aung PP, Khangura S, Kamal N, Gallin JI, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–72.CrossRefPubMedPubMedCentral Alimchandani M, Lai J-P, Aung PP, Khangura S, Kamal N, Gallin JI, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013;37:1365–72.CrossRefPubMedPubMedCentral
54.••
Zurück zum Zitat Khangura SK, Kamal N, Ho N, Quezado M, Zhao X, Marciano B, et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. Elsevier Ltd; 2015; ••211 GI tract endoscopies were performed at the NIH on 78 CGD patients.. Inflammatory lesions were frequent in all parts of the GI tract with a classically skip pattern. Ano-rectal area was the most often involved GI tract part (93% of patients with colonic inflammation) including sometimes fistulae. Khangura SK, Kamal N, Ho N, Quezado M, Zhao X, Marciano B, et al. Gastrointestinal features of chronic granulomatous disease found during endoscopy. Clin Gastroenterol Hepatol. Elsevier Ltd; 2015; ••211 GI tract endoscopies were performed at the NIH on 78 CGD patients.. Inflammatory lesions were frequent in all parts of the GI tract with a classically skip pattern. Ano-rectal area was the most often involved GI tract part (93% of patients with colonic inflammation) including sometimes fistulae.
55.
Zurück zum Zitat Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132:997–1000. e1–4.CrossRefPubMed Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, et al. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series. J Allergy Clin Immunol. 2013;132:997–1000. e1–4.CrossRefPubMed
56.
Zurück zum Zitat Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr. 1995;126:143–5.CrossRefPubMed Rosh JR, Tang HB, Mayer L, Groisman G, Abraham SK, Prince A. Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr. 1995;126:143–5.CrossRefPubMed
57.
Zurück zum Zitat Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–34.CrossRefPubMedPubMedCentral Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010;51:1429–34.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut. 1998;42:127–30.CrossRefPubMedPubMedCentral Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut. 1998;42:127–30.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436–48.CrossRef Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet (London, England). 2014;383:436–48.CrossRef
Metadaten
Titel
Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)
verfasst von
Mathieu Uzzan
Huaibin M. Ko
Saurabh Mehandru
Charlotte Cunningham-Rundles
Publikationsdatum
01.04.2016
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 4/2016
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-016-0491-3

Weitere Artikel der Ausgabe 4/2016

Current Gastroenterology Reports 4/2016 Zur Ausgabe

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao, Section Editor)

Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease

Pediatric Gastroenterology (SR Orenstein, Section Editor)

Pain Measurement in Children with Functional Abdominal Pain

Nutrition and Obesity (SA McClave, Section Editor)

Vitamin D Status and Supplementation in the Critically Ill

Nutrition and Obesity (SA McClave, Section Editor)

Can Nutritional Assessment Tools Predict Response to Nutritional Therapy?

Small Intestine (D Sachar, Section Editor)

Small Bowel Congenital Anomalies: a Review and Update

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.